First Time Loading...

Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 115.67 USD -1.75% Market Closed
Updated: Jun 1, 2023

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Agilent Technologies Inc

Revenue
7B USD
Cost of Revenue
-3.2B USD
Gross Profit
3.8B USD
Operating Expenses
-2.2B USD
Operating Income
1.7B USD
Other Expenses
-340M USD
Net Income
1.4B USD

Margins Comparison
Agilent Technologies Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Agilent Technologies Inc
NYSE:A
34.1B USD
55%
24%
19%
US
Thermo Fisher Scientific Inc
NYSE:TMO
196B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
167B USD
60%
27%
22%
CH
Lonza Group AG
SIX:LONN
42.8B CHF
39%
25%
20%
KR
Samsung Biologics Co Ltd
KRX:207940
56.1T KRW
49%
31%
25%
US
IQVIA Holdings Inc
NYSE:IQV
36.5B USD
35%
13%
7%
US
Illumina Inc
NASDAQ:ILMN
31.1B USD
63%
2%
-101%
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
59%
29%
22%
CN
WuXi AppTec Co Ltd
SSE:603259
199B CNY
37%
24%
22%
US
West Pharmaceutical Services Inc
NYSE:WST
24.8B USD
39%
25%
19%
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.2B EUR
52%
26%
21%
Country US
Market Cap 34.1B USD
Gross Margin
55%
Operating Margin
24%
Net Margin
19%
Country US
Market Cap 196B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 167B USD
Gross Margin
60%
Operating Margin
27%
Net Margin
22%
Country CH
Market Cap 42.8B CHF
Gross Margin
39%
Operating Margin
25%
Net Margin
20%
Country KR
Market Cap 56.1T KRW
Gross Margin
49%
Operating Margin
31%
Net Margin
25%
Country US
Market Cap 36.5B USD
Gross Margin
35%
Operating Margin
13%
Net Margin
7%
Country US
Market Cap 31.1B USD
Gross Margin
63%
Operating Margin
2%
Net Margin
-101%
Country US
Market Cap 29.1B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
22%
Country CN
Market Cap 199B CNY
Gross Margin
37%
Operating Margin
24%
Net Margin
22%
Country US
Market Cap 24.8B USD
Gross Margin
39%
Operating Margin
25%
Net Margin
19%
Country FR
Market Cap 23.2B EUR
Gross Margin
52%
Operating Margin
26%
Net Margin
21%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Agilent Technologies Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Agilent Technologies Inc
NYSE:A
34.1B USD
25%
13%
19%
16%
US
Thermo Fisher Scientific Inc
NYSE:TMO
196B USD
15%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
167B USD
14%
8%
11%
9%
CH
Lonza Group AG
SIX:LONN
42.8B CHF
12%
7%
11%
9%
KR
Samsung Biologics Co Ltd
KRX:207940
56.1T KRW
12%
7%
11%
8%
US
IQVIA Holdings Inc
NYSE:IQV
36.5B USD
18%
4%
9%
7%
US
Illumina Inc
NASDAQ:ILMN
31.1B USD
-51%
-33%
1%
1%
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
2 951%
26%
50%
31%
CN
WuXi AppTec Co Ltd
SSE:603259
199B CNY
21%
15%
20%
16%
US
West Pharmaceutical Services Inc
NYSE:WST
24.8B USD
22%
16%
25%
24%
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.2B EUR
33%
16%
25%
17%
Country US
Market Cap 34.1B USD
ROE
25%
ROA
13%
ROCE
19%
ROIC
16%
Country US
Market Cap 196B USD
ROE
15%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 167B USD
ROE
14%
ROA
8%
ROCE
11%
ROIC
9%
Country CH
Market Cap 42.8B CHF
ROE
12%
ROA
7%
ROCE
11%
ROIC
9%
Country KR
Market Cap 56.1T KRW
ROE
12%
ROA
7%
ROCE
11%
ROIC
8%
Country US
Market Cap 36.5B USD
ROE
18%
ROA
4%
ROCE
9%
ROIC
7%
Country US
Market Cap 31.1B USD
ROE
-51%
ROA
-33%
ROCE
1%
ROIC
1%
Country US
Market Cap 29.1B USD
ROE
2 951%
ROA
26%
ROCE
50%
ROIC
31%
Country CN
Market Cap 199B CNY
ROE
21%
ROA
15%
ROCE
20%
ROIC
16%
Country US
Market Cap 24.8B USD
ROE
22%
ROA
16%
ROCE
25%
ROIC
24%
Country FR
Market Cap 23.2B EUR
ROE
33%
ROA
16%
ROCE
25%
ROIC
17%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Similar Stocks